Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Idexx Laboratories, Inc shares valued at $645,545 were sold by SZOSTAK M ANNE on May 21 ’25. At $512.34 per share, SZOSTAK M ANNE sold 1,260 shares. The insider’s holdings dropped to 1,801 shares worth approximately $0.99 million following the completion of this transaction.
Also, SZOSTAK M ANNE sold 1,046 shares, netting a total of over 537,372 in proceeds. Following the sale of shares at $513.74 each, the insider now holds 262 shares.
Before that, SZOSTAK M ANNE had added 1,260 shares to its account. In a trade valued at $651,621, the Director bought Idexx Laboratories, Inc shares for $517.16 each.
As published in their initiating research note from Jefferies on July 01, 2025, Idexx Laboratories, Inc [IDXX] has been a Buy and the price target has been revised to $625. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in early December. As of July 25, 2024, BTIG Research has initiated its “Buy” rating for IDXX. Earlier on January 30, 2024, Piper Sandler downgraded its rating. Their new recommendation was “a Neutral” for IDXX stock which previously was a “an Overweight”.
Analyzing IDXX Stock Performance
On last trading session, Idexx Laboratories, Inc [NASDAQ: IDXX] rose 0.79% to $547.01. The stock’s lowest price that day was $537.11, but it reached a high of $548.54 in the same session. During the last five days, there has been a surge of approximately 3.64%. Over the course of the year, Idexx Laboratories, Inc shares have jumped approximately 14.82%. Shares of the company reached a 52-week high of $548.54 on 07/03/25 and a 52-week low of $356.14 on 04/09/25.
Support And Resistance Levels for Idexx Laboratories, Inc (IDXX)
According to the 24-hour chart, there is a support level at 539.83, which, if violated, would cause prices to drop to 532.64. In the upper region, resistance lies at 551.37. The next price resistance is at 555.72. RSI (Relative Strength Index) is 72.15 on the 14-day chart, showing overbought technical sentiment.
Is Idexx Laboratories, Inc subject to short interest?
Stocks of Idexx Laboratories, Inc saw a sharp steep in short interest on 2025-06-13 dropping by -0.49 million shares to 2.54 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 3.03 million shares. A decline of -19.23% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.98 of the overall float, the days-to-cover ratio (short ratio) decline to 4.98.
Which companies own the most shares of Idexx Laboratories, Inc (IDXX)?
In terms of Idexx Laboratories, Inc share price expectations, FactSet research, analysts set an average price target of 536.5 in the next 12 months, down nearly -1.14% from the previous closing price of $542.71. Analysts anticipate Idexx Laboratories, Inc stock to reach 600 by 2025, with the lowest price target being 247. In spite of this, 6 analysts ranked Idexx Laboratories, Inc stock as Buy at the end of 2025. On December 07, 2023, Exane BNP Paribas assigned a price target of “an Outperform” to the stock and initiated coverage with a $602.
